Use of histone deacetylase inhibitors in combination with radiation for the treatment of cancer

作者: George Sgouros , Victoria M. Richon , Paul A. Marks , Richard A. Rifkind

DOI:

关键词: Histone deacetylaseRadiation therapyHDAC inhibitorHistone deacetylase inhibitorMedicinePharmacologyCancerTreatment procedure

摘要: The present invention relates to a method for the treatment of cancer in patient need thereof. comprises administering thereof first amount histone deacetylase inhibitor procedure, and second or dose radiation procedure. treatments together comprise therapeutically effective amount. combination HDAC therapy is synergistic.

参考文章(34)
Richard A. Rifkind, Paul A. Marks, Ronald Breslow, Novel potent inducers of terminal differentiation and methods of use thereof ,(1995)
Marco Gottardis, Matthew V. Lorenzi, Ricardo M. Attar, Donald G. Jackson, Novel human histone deacetylases ,(2002)
Sandro Belvedere, Richard A. Rifkind, Paul A. Marks, Ronald Breslow, Thomas A. Miller, Victoria M. Richon, Hydroxamic acid compounds and methods of use thereof ,(2004)
Motohiro Hino, Shigehiro Takase, Hiroaki Mori, Yasuhisa Tsurumi, Kazutoshi Sakamoto, Cyclic tetrapeptide compound and use thereof ,(1999)
Richard A. Rifkind, Paul A. Marks, Ronald Breslow, Sandro Pontremoli, Method for increasing sensitivity to chemically induced terminal differentiation ,(1988)
Norbert L. Wiech, Hsuan-Yin Lan-Hargest, Methods for using alkanoyloxymethyl esters ,(2000)
A. Zelent, R. P. Warrell, P. P. olo Pandolfi, Transcription therapy for cancers Official Gazette of the United States Patent and Trademark Office Patents. ,(2001)
Laszlo Bodai, Judit Pallos, J. Lawrence Marsh, Joan S. Steffan, Leslie M. Thompson, Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors ,(2002)